TransAct Historical Cash Flow

TACT Stock

USD 4.16 0.01 0.24%

Analysis of TransAct Technologies cash flow over time is an excellent tool to project TransAct Technologies future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Capital Expenditures of 1.1 M or Total Cash From Operating Activities of 5.8 M as it is a great indicator of TransAct Technologies ability to facilitate future growth, repay debt on time or pay out dividends.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining TransAct Technologies latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether TransAct Technologies is a good buy for the upcoming year.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TransAct Technologies Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

About TransAct Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in TransAct balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which TransAct's non-liquid assets can be easily converted into cash.

TransAct Technologies Cash Flow Chart

At this time, TransAct Technologies' Net Borrowings is comparatively stable compared to the past year. Exchange Rate Changes is likely to gain to about 77.3 K in 2024, whereas Stock Based Compensation is likely to drop slightly above 669.4 K in 2024.

Other Non Cash Items Capital Expenditures End Period Cash Flow Begin Period Cash Flow

Capital Expenditures

Capital Expenditures are funds used by TransAct Technologies to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of TransAct Technologies operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Most accounts from TransAct Technologies' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into TransAct Technologies current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TransAct Technologies Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

	2021	2022	2023	2024 (projected)
Begin Period Cash Flow	10.4M	19.5M	7.9M	5.2M
End Period Cash Flow	19.5M	7.9M	12.3M	12.9M

Begin Period Cash Flow End Period Cash Flow

TransAct Technologies cash flow statement Correlations

	Sale Purchase Of Stock	Change To Inventory	Change In Cash	Stock Based Compensation	Free Cash Flow	Change In Working Capital	Depreciation	Other Non Cash Items	Capital Expenditures	Net Income	End Period Cash Flow	Begin Period Cash Flow	Dividends Paid	Change To Account Receivables	Change Receivables	Net Borrowings	Exchange Rate Changes	Cash And Cash Equivalents Changes	Cash Flows Other Operating	Change To Netincome	Change To Liabilities	Change To Operating Activities	Investments	Issuance Of Capital Stock
Sale Purchase Of Stock		-0.31	0.36	0.32	-0.41	-0.1	-0.65	-0.18	0.25	-0.39	0.47	0.08	-0.34	0.25	-0.15	0.6	0.62	-0.27	-0.22	-0.26	0.2	-0.52	-0.18	-0.41
Change To Inventory	-0.31		0.3	-0.05	0.15	0.71	-0.02	-0.4	-0.13	-0.31	-0.03	-0.29	0.18	-0.48	0.1	-0.31	-0.47	0.5	-0.03	0.03	-0.11	0.01	0.73	0.77
Change In Cash	0.36	0.3		0.08	0.35	0.53	-0.36	-0.41	-0.06	-0.03	0.56	-0.52	-0.16	0.3	-0.1	0.29	0.27	0.13	-0.2	-0.23	0.22	-0.29	0.39	0.2
Stock Based Compensation	0.32	-0.05	0.08		-0.47	-0.02	-0.08	-0.47	-0.23	-0.53	0.72	0.65	-0.21	-0.3	-0.5	0.63	0.6	-0.33	0.03	-0.54	0.6	-0.44	-0.01	-0.3
Free Cash Flow	-0.41	0.15	0.35	-0.47		0.4	0.23	0.3	-0.26	0.73	-0.28	-0.72	0.48	0.41	0.2	-0.42	-0.39	0.38	0.25	0.38	-0.01	0.1	-0.04	0.24
Change In Working Capital	-0.1	0.71	0.53	-0.02	0.4		-0.12	-0.22	-0.22	-0.3	0.06	-0.49	0.32	-0.01	0.15	-0.06	-0.15	0.39	0.28	-0.23	0.11	-0.01	0.44	0.48
Depreciation	-0.65	-0.02	-0.36	-0.08	0.23	-0.12		0.25	-0.47	0.23	-0.2	0.16	-0.05	0.04	0.02	-0.14	-0.35	0.09	0.12	0.15	-0.02	0.46	0.03	-0.13
Other Non Cash Items	-0.18	-0.4	-0.41	-0.47	0.3	-0.22	0.25		-0.16	0.36	-0.71	-0.33	0.38	0.32	0.36	-0.31	-0.18	0.43	-0.1	0.67	-0.1	0.1	-0.74	-0.26
Capital Expenditures	0.25	-0.13	-0.06	-0.23	-0.26	-0.22	-0.47	-0.16		0.05	0.06	0.15	-0.31	-0.13	-0.08	0.09	0.31	-0.33	0.06	-0.06	-0.16	0.09	-0.11	0.01
Net Income	-0.39	-0.31	-0.03	-0.53	0.73	-0.3	0.23	0.36	0.05		-0.34	-0.37	0.26	0.36	0.08	-0.45	-0.32	0.02	0.13	0.49	-0.15	0.16	-0.28	-0.02
End Period Cash Flow	0.47	-0.03	0.56	0.72	-0.28	0.06	-0.2	-0.71	0.06	-0.34		0.4	-0.62	-0.09	-0.63	0.73	0.66	-0.5	-0.01	-0.7	0.58	-0.28	0.24	-0.3
Begin Period Cash Flow	0.08	-0.29	-0.52	0.65	-0.72	-0.49	0.16	-0.33	0.15	-0.37	0.4		-0.47	-0.48	-0.51	0.39	0.35	-0.63	0.18	-0.47	0.3	0.04	-0.11	-0.44
Dividends Paid	-0.34	0.18	-0.16	-0.21	0.48	0.32	-0.05	0.38	-0.31	0.26	-0.62	-0.47		0.1	0.52	-0.53	-0.41	0.53	0.19	0.48	-0.2	-0.22	-0.16	0.44
Change To Account Receivables	0.25	-0.48	0.3	-0.3	0.41	-0.01	0.04	0.32	-0.13	0.36	-0.09	-0.48	0.1		0.51	0.08	0.17	0.09	-0.13	0.14	-0.31	0.05	-0.28	-0.18
Change Receivables	-0.15	0.1	-0.1	-0.5	0.2	0.15	0.02	0.36	-0.08	0.08	-0.63	-0.51	0.52	0.51		-0.52	-0.35	0.64	-0.35	0.54	-0.82	0.17	0.01	0.55
Net Borrowings	0.6	-0.31	0.29	0.63	-0.42	-0.06	-0.14	-0.31	0.09	-0.45	0.73	0.39	-0.53	0.08	-0.52		0.85	-0.52	0.01	-0.62	0.56	-0.32	-0.12	-0.61
Exchange Rate Changes	0.62	-0.47	0.27	0.6	-0.39	-0.15	-0.35	-0.18	0.31	-0.32	0.66	0.35	-0.41	0.17	-0.35	0.85		-0.42	-0.1	-0.47	0.48	-0.4	-0.37	-0.52
Cash And Cash Equivalents Changes	-0.27	0.5	0.13	-0.33	0.38	0.39	0.09	0.43	-0.33	0.02	-0.5	-0.63	0.53	0.09	0.64	-0.52	-0.42		-0.49	0.72	-0.34	-0.05	0.03	0.6
Cash Flows Other Operating	-0.22	-0.03	-0.2	0.03	0.25	0.28	0.12	-0.1	0.06	0.13	-0.01	0.18	0.19	-0.13	-0.35	0.01	-0.1	-0.49		-0.46	0.35	0.15	-0.04	-0.23
Change To Netincome	-0.26	0.03	-0.23	-0.54	0.38	-0.23	0.15	0.67	-0.06	0.49	-0.7	-0.47	0.48	0.14	0.54	-0.62	-0.47	0.72	-0.46		-0.43	-0.01	-0.32	0.3
Change To Liabilities	0.2	-0.11	0.22	0.6	-0.01	0.11	-0.02	-0.1	-0.16	-0.15	0.58	0.3	-0.2	-0.31	-0.82	0.56	0.48	-0.34	0.35	-0.43		-0.43	-0.23	-0.56
Change To Operating Activities	-0.52	0.01	-0.29	-0.44	0.1	-0.01	0.46	0.1	0.09	0.16	-0.28	0.04	-0.22	0.05	0.17	-0.32	-0.4	-0.05	0.15	-0.01	-0.43		0.11	0.08
Investments	-0.18	0.73	0.39	-0.01	-0.04	0.44	0.03	-0.74	-0.11	-0.28	0.24	-0.11	-0.16	-0.28	0.01	-0.12	-0.37	0.03	-0.04	-0.32	-0.23	0.11		0.62
Issuance Of Capital Stock	-0.41	0.77	0.2	-0.3	0.24	0.48	-0.13	-0.26	0.01	-0.02	-0.3	-0.44	0.44	-0.18	0.55	-0.61	-0.52	0.6	-0.23	0.3	-0.56	0.08	0.62

Click cells to compare fundamentals

TransAct Technologies Account Relationship Matchups

TransAct Technologies cash flow statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Change To Inventory	796K	876K	3.6M	(4.4M)	(5.7M)	(5.4M)
Change In Cash	(488K)	6.2M	9.1M	(11.5M)	4.4M	4.6M
Stock Based Compensation	692K	876K	1.2M	1.2M	860K	669.4K
Free Cash Flow	3.5M	(4.3M)	(3.9M)	(13.5M)	4.6M	4.8M
Change In Working Capital	2.5M	328K	3.5M	(6.6M)	(2.6M)	(2.5M)
Other Cashflows From Financing Activities	1.8M	(940K)	(742K)	(188K)	(87K)	(91.4K)
Depreciation	1.4M	1.3M	957K	1.3M	1.5M	1.3M
Other Non Cash Items	34K	(59K)	(1.9M)	8K	(30K)	(28.5K)
Capital Expenditures	1.4M	744K	1.4M	1.3M	901K	1.1M
Total Cash From Operating Activities	4.8M	(3.5M)	(2.5M)	(12.2M)	5.5M	5.8M
Net Income	516K	(5.6M)	(4.1M)	(5.9M)	4.7M	5.0M
Total Cash From Financing Activities	(2.9M)	11.0M	11.5M	2.1M	(87K)	(91.4K)
End Period Cash Flow	4.2M	10.4M	19.5M	7.9M	12.3M	12.9M
Begin Period Cash Flow	4.7M	4.2M	10.4M	19.5M	7.9M	5.2M
Dividends Paid	2.6M	2.7M	2.7M	41K	47.2K	44.8K
Other Cashflows From Investing Activities	(466K)	(304K)	(600K)	1.6M	1.8M	1.9M
Change To Account Receivables	1.6M	3.0M	(4.2M)	(6.4M)	5.7M	6.0M
Change Receivables	2.7M	1.6M	3.0M	(6.4M)	(5.8M)	(5.5M)
Net Borrowings	2.2M	2.0M	2.3M	2.2M	2.5M	2.6M
Total Cashflows From Investing Activities	(2.4M)	(1.3M)	222K	(1.3M)	(1.5M)	(1.6M)
Cash And Cash Equivalents Changes	(816K)	(417K)	6.2M	(11.5M)	(10.3M)	(9.8M)
Cash Flows Other Operating	(261K)	244K	(2.4M)	304K	273.6K	287.3K
Change To Netincome	432K	450K	(2.8M)	(978K)	(880.2K)	(836.2K)
Change To Liabilities	(102K)	(1.1M)	2.5M	3.9M	4.4M	4.7M
Change To Operating Activities	82K	(22K)	(586K)	921K	828.9K	870.3K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for TransAct Stock Analysis

When running TransAct Technologies' price analysis, check to measure TransAct Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TransAct Technologies is operating at the current time. Most of TransAct Technologies' value examination focuses on studying past and present price action to predict the probability of TransAct Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TransAct Technologies' price. Additionally, you may evaluate how the addition of TransAct Technologies to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

TransAct Historical Cash Flow

About TransAct Cash Flow Analysis

TransAct Technologies Cash Flow Chart

Capital Expenditures

Begin Period Cash Flow

TransAct Technologies cash flow statement Correlations

TransAct Technologies Account Relationship Matchups

High Positive Relationship

High Negative Relationship

TransAct Technologies cash flow statement Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for TransAct Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Exchange Rate Changes	+ 0.85	Net Borrowings
Issuance Of Capital Stock	+ 0.77	Change To Inventory
Investments	+ 0.73	Change To Inventory
Net Income	+ 0.73	Free Cash Flow
Net Borrowings	+ 0.73	End Period Cash Flow
End Period Cash Flow	+ 0.72	Stock Based Compensation

Change To Liabilities	- 0.82	Change Receivables
Investments	- 0.74	Other Non Cash Items
Begin Period Cash Flow	- 0.72	Free Cash Flow
End Period Cash Flow	- 0.71	Other Non Cash Items
Change To Netincome	- 0.7	End Period Cash Flow
Depreciation	- 0.65	Sale Purchase Of Stock